| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2022 | 8.86% | Wedbush | → $14 | Assumes | → Neutral |
| 09/12/2022 | 20.53% | Deutsche Bank | $16.5 → $15.5 | Maintains | Hold |
| 07/28/2022 | 16.64% | Argus Research | → $15 | Upgrades | Hold → Buy |
| 07/22/2022 | 32.19% | Raymond James | $16 → $17 | Maintains | Strong Buy |
| 07/12/2022 | 8.86% | Morgan Stanley | $17 → $14 | Maintains | Equal-Weight |
| 07/08/2022 | 4.98% | Piper Sandler | $14 → $13.5 | Downgrades | Overweight → Neutral |
| 07/07/2022 | 24.42% | Raymond James | $18 → $16 | Maintains | Strong Buy |
| 07/01/2022 | 12.75% | JP Morgan | $17.5 → $14.5 | Downgrades | Overweight → Neutral |
| 06/30/2022 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 06/03/2022 | — | Keefe, Bruyette & Woods | Downgrades | Market Perform → Underperform | |
| 05/31/2022 | 12.75% | Goldman Sachs | $17.5 → $14.5 | Maintains | Buy |
| 04/25/2022 | 32.19% | Stephens & Co. | $16 → $17 | Upgrades | Equal-Weight → Overweight |
| 04/22/2022 | 39.97% | Raymond James | $19 → $18 | Maintains | Strong Buy |
| 04/08/2022 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 03/28/2022 | 32.19% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight |
| 01/24/2022 | 39.97% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight |
| 01/24/2022 | 47.74% | Raymond James | $20 → $19 | Maintains | Strong Buy |
| 01/13/2022 | 63.3% | UBS | → $21 | Initiates Coverage On | → Buy |
| 01/03/2022 | 32.19% | Barclays | → $17 | Downgrades | Equal-Weight → Underweight |
| 12/06/2021 | 47.74% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight |
| 11/17/2021 | 39.97% | Wolfe Research | $20 → $18 | Downgrades | Outperform → Peer Perform |
| 10/07/2021 | 55.52% | Raymond James | $18 → $20 | Maintains | Strong Buy |
| 08/02/2021 | 45.8% | Morgan Stanley | $18.5 → $18.75 | Maintains | Equal-Weight |
| 06/23/2021 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 04/01/2021 | 24.42% | Deutsche Bank | $14 → $16 | Maintains | Hold |
| 03/24/2021 | 39.97% | Raymond James | $15 → $18 | Maintains | Outperform |
| 03/18/2021 | 43.86% | Morgan Stanley | $17.25 → $18.5 | Maintains | Equal-Weight |
| 02/24/2021 | 34.14% | Morgan Stanley | $16.25 → $17.25 | Maintains | Equal-Weight |
| 01/25/2021 | 16.64% | Raymond James | $14 → $15 | Maintains | Outperform |
| 01/07/2021 | 26.36% | Morgan Stanley | $15 → $16.25 | Maintains | Equal-Weight |
| 01/05/2021 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 12/17/2020 | 8.86% | Stephens & Co. | → $14 | Downgrades | Overweight → Equal-Weight |
| 12/15/2020 | 8.86% | Raymond James | $12 → $14 | Maintains | Outperform |
| 12/07/2020 | 16.64% | Morgan Stanley | $12 → $15 | Maintains | Equal-Weight |
| 11/03/2020 | -6.69% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 10/26/2020 | -2.8% | Wedbush | $10.5 → $12.5 | Upgrades | Neutral → Outperform |
| 09/29/2020 | -22.24% | Piper Sandler | $10.5 → $10 | Maintains | Neutral |
| 07/24/2020 | -22.24% | BMO Capital | $9 → $10 | Maintains | Market Perform |
| 07/10/2020 | -14.46% | B of A Securities | $12 → $11 | Maintains | Buy |
| 06/11/2020 | -6.69% | RBC Capital | $10 → $12 | Maintains | Outperform |
| 06/08/2020 | -14.46% | Morgan Stanley | $10.5 → $11 | Maintains | Equal-Weight |
| 05/15/2020 | -37.79% | UBS | $7.5 → $8 | Maintains | Neutral |
| 04/27/2020 | -22.24% | Raymond James | $11.5 → $10 | Maintains | Outperform |
| 04/24/2020 | -30.02% | Stephens & Co. | $11 → $9 | Maintains | Equal-Weight |
| 04/24/2020 | -22.24% | RBC Capital | $11 → $10 | Maintains | Outperform |
| 04/07/2020 | -18.35% | Morgan Stanley | $13 → $10.5 | Maintains | Equal-Weight |
| 04/07/2020 | -45.57% | Nomura | $14 → $7 | Maintains | Neutral |
| 04/06/2020 | -30.02% | CFRA | $15 → $9 | Maintains | Hold |
| 04/02/2020 | -22.24% | Deutsche Bank | $15 → $10 | Maintains | Hold |
| 03/17/2020 | 1.09% | Morgan Stanley | $13.5 → $13 | Maintains | Equal-Weight |
| 03/09/2020 | 16.64% | Baird | → $15 | Upgrades | Neutral → Outperform |
| 03/05/2020 | 10.81% | Morgan Stanley | $15.5 → $14.25 | Maintains | Equal-Weight |
| 02/26/2020 | 24.42% | B of A Securities | $15 → $16 | Upgrades | Neutral → Buy |
| 01/31/2020 | — | BMO Capital | Upgrades | Underperform → Market Perform | |
| 01/24/2020 | 20.53% | Raymond James | $17 → $15.5 | Maintains | Outperform |
| 01/06/2020 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 12/13/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 10/25/2019 | 24.42% | Raymond James | $14 → $16 | Maintains | Outperform |
| 10/25/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 09/13/2019 | 24.42% | DA Davidson | → $16 | Downgrades | Buy → Neutral |
| 07/12/2019 | — | Macquarie | Downgrades | Neutral → Underperform | |
| 07/08/2019 | 8.86% | BMO Capital | → $14 | Downgrades | Market Perform → Underperform |
| 05/31/2019 | — | Argus Research | Initiates Coverage On | → Hold | |
| 01/28/2019 | 8.86% | Jefferies | → $14 | Downgrades | Buy → Hold |
| 11/29/2018 | — | Piper Sandler | Downgrades | Buy → Hold | |
| 11/16/2018 | 24.42% | Raymond James | $15.5 → $16 | Maintains | Outperform |
| 11/13/2018 | 16.64% | Nomura | → $15 | Downgrades | Buy → Neutral |
| 11/02/2018 | 24.42% | Wedbush | $18 → $16 | Downgrades | Outperform → Neutral |
| 10/24/2018 | 20.53% | Raymond James | $17 → $15.5 | Maintains | Outperform |
| 10/24/2018 | 16.64% | BMO Capital | $17 → $15 | Maintains | Market Perform |
| 09/18/2018 | 36.08% | Morgan Stanley | $17.75 → $17.5 | Maintains | Equal-Weight |
| 08/08/2018 | 39.97% | Jefferies | $17 → $18 | Maintains | Buy |
| 04/25/2018 | 32.19% | Nomura | $18 → $17 | Maintains | Buy |
| 03/22/2018 | 55.52% | UBS | → $20 | Initiates Coverage On | → Buy |
| 02/09/2018 | — | Hilliard Lyons | Upgrades | Neutral → Buy | |
| 01/26/2018 | 32.19% | Morgan Stanley | $16.5 → $17 | Maintains | Equal-Weight |
| 01/25/2018 | 32.19% | JP Morgan | $16 → $17 | Maintains | Neutral |
| 01/24/2018 | — | Hilliard Lyons | Downgrades | Buy → Neutral | |
| 01/24/2018 | 39.97% | B of A Securities | $17 → $18 | Maintains | Buy |
| 12/13/2017 | 28.3% | Morgan Stanley | $14.5 → $16.5 | Maintains | Equal-Weight |
| 10/26/2017 | 32.19% | Nomura | $16 → $17 | Maintains | Buy |
| 10/26/2017 | — | BMO Capital | Downgrades | Outperform → Market Perform |
Huntington Bancshares Questions & Answers
What is the target price for Huntington Bancshares (HBAN)?
The latest price target for Huntington Bancshares (NASDAQ: HBAN) was reported by Wedbush on September 28, 2022. The analyst firm set a price target for $14.00 expecting HBAN to rise to within 12 months (a possible 8.86% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Huntington Bancshares (HBAN)?
The latest analyst rating for Huntington Bancshares (NASDAQ: HBAN) was provided by Wedbush, and Huntington Bancshares their neutral rating.
When is the next analyst rating going to be posted or updated for Huntington Bancshares (HBAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Huntington Bancshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Huntington Bancshares was filed on September 28, 2022 so you should expect the next rating to be made available sometime around September 28, 2023.
Is the Analyst Rating Huntington Bancshares (HBAN) correct?
While ratings are subjective and will change, the latest Huntington Bancshares (HBAN) rating was a with a price target of $0.00 to $14.00. The current price Huntington Bancshares (HBAN) is trading at is $12.86, which is within the analyst's predicted range.